Evidence map›Paper›PMID 32093264›Full record

ArticleMolecules (Basel, Switzerland)2020

Betulinic Acid-Nitrogen Heterocyclic Derivatives: Design, Synthesis, and Antitumor Evaluation

Yuqin Yang, Tianxin Xie, Xuehao Tian, Nana Han, Xiaojing Liu, Hongshan Chen, Jinchai Qi, Feng Gao, Wen Li, Qianwen Wu and 5 more

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.2field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. International journal of molecular sciences · 2022
    Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 1 institution in 1 country.

Yuqin YangSchool of Chinese Pharmacy, Beijing University of Chinese Medicine, Beijing 102488, China.
Tianxin XieSchool of Chinese Pharmacy, Beijing University of Chinese Medicine, Beijing 102488, China.
Xuehao TianSchool of Chinese Pharmacy, Beijing University of Chinese Medicine, Beijing 102488, China.
Nana HanSchool of Chinese Pharmacy, Beijing University of Chinese Medicine, Beijing 102488, China.
Xiaojing LiuSchool of Chinese Pharmacy, Beijing University of Chinese Medicine, Beijing 102488, China.
Hongshan ChenSchool of Chinese Pharmacy, Beijing University of Chinese Medicine, Beijing 102488, China.
Jinchai QiSchool of Chinese Pharmacy, Beijing University of Chinese Medicine, Beijing 102488, China.
Feng GaoSchool of Chinese Pharmacy, Beijing University of Chinese Medicine, Beijing 102488, China.
Wen LiSchool of Chinese Pharmacy, Beijing University of Chinese Medicine, Beijing 102488, China.
Qianwen WuSchool of Chinese Pharmacy, Beijing University of Chinese Medicine, Beijing 102488, China.
Su HuoSchool of Chinese Pharmacy, Beijing University of Chinese Medicine, Beijing 102488, China.
Yuhao GuSchool of Chinese Pharmacy, Beijing University of Chinese Medicine, Beijing 102488, China.
Ziqi DaiSchool of Chinese Pharmacy, Beijing University of Chinese Medicine, Beijing 102488, China.
Penglong WangSchool of Chinese Pharmacy, Beijing University of Chinese Medicine, Beijing 102488, China.
Haimin LeiSchool of Chinese Pharmacy, Beijing University of Chinese Medicine, Beijing 102488, China.ORCID 0000-0001-6765-9545
Beijing University of Chinese Medicine · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Betulinic acid (

Indexed as

Antineoplastic AgentsCytotoxinsBetulinic AcidDrug Screening Assays, AntitumorHeLa CellsHep G2 CellsHumansNeoplasmsPentacyclic TriterpenesStructure-Activity RelationshipTriterpenesAntineoplastic AgentsBetulinic AcidCytotoxinsPentacyclic TriterpenesTriterpenesantitumorBA-nitrogen heterocyclic derivativesbetulinic acidflow cytometryHela

Identifiers

PMID32093264
PMCPMC7070564
OpenAlexW3008895036

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.